10% Owner of iTeos Therapeutics, Inc. (U.S.: Nasdaq:ITOS), Gadicke Ansbert, sells 21,210 shares worth $758,282
According to iTeos Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 30 04:49 PM, company 10% Owner, Gadicke Ansbert disclosed selling 21,210 shares at a cost of $35.75. At the time of this transaction (Nov 26), this trade was worth $758,282 in total. As of Nov 26, Gadicke Ansbert now owns 4,970,716 shares in total worth about $175,466,274.79999998.
For the last few recent trades made by iTeos Therapeutics, Inc. (U.S.: Nasdaq:ITOS) 10% Owner, Gadicke Ansbert, we have the following information:
- SEC Form 4 filing: Nov 29: Sold 17,356 shares at the rate of $34.49 per share. Total worth of this trade was $598,543. Total number of shares owned as of Nov 29 were 4,953,360
- SEC Form 4 filing: Nov 22: Sold 35,333 shares at the rate of $37.52 per share. Total worth of this trade was $1,325,817. Total number of shares owned as of Nov 22 were 5,086,210
- SEC Form 4 filing: Nov 23: Sold 33,476 shares at the rate of $36.22 per share. Total worth of this trade was $1,212,340. Total number of shares owned as of Nov 23 were 5,052,734
Posted by
George Daniels
on Tuesday November 30 2021, 10:47 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
